Literature DB >> 30021888

Selective neuronal silencing using synthetic botulinum molecules alleviates chronic pain in mice.

Maria Maiarù1, Charlotte Leese2, Michelangelo Certo1, Irene Echeverria-Altuna1, Antonina S Mangione1, Jason Arsenault3, Bazbek Davletov4, Stephen P Hunt5.   

Abstract

Chronic pain is a widespread debilitating condition affecting millions of people worldwide. Although several pharmacological treatments for relieving chronic pain have been developed, they require frequent chronic administration and are often associated with severe adverse events, including overdose and addiction. Persistent increased sensitization of neuronal subpopulations of the peripheral and central nervous system has been recognized as a central mechanism mediating chronic pain, suggesting that inhibition of specific neuronal subpopulations might produce antinociceptive effects. We leveraged the neurotoxic properties of the botulinum toxin to specifically silence key pain-processing neurons in the spinal cords of mice. We show that a single intrathecal injection of botulinum toxin conjugates produced long-lasting pain relief in mouse models of inflammatory and neuropathic pain without toxic side effects. Our results suggest that this strategy might be a safe and effective approach for relieving chronic pain while avoiding the adverse events associated with repeated chronic drug administration.
Copyright © 2018 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30021888     DOI: 10.1126/scitranslmed.aar7384

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN: 1946-6234            Impact factor:   17.956


  11 in total

1.  Pain: Silencing chronic pain with botulinum toxin.

Authors:  Sarah Crunkhorn
Journal:  Nat Rev Drug Discov       Date:  2018-08-17       Impact factor: 84.694

2.  Pathophysiological Mechanisms in Migraine and the Identification of New Therapeutic Targets.

Authors:  Kristian Agmund Haanes; Lars Edvinsson
Journal:  CNS Drugs       Date:  2019-06       Impact factor: 5.749

Review 3.  A functional subdivision within the somatosensory system and its implications for pain research.

Authors:  Qiufu Ma
Journal:  Neuron       Date:  2022-01-10       Impact factor: 17.173

4.  Interactions between nociceptor sensory neurons and microbial pathogens in pain.

Authors:  Larissa Staurengo-Ferrari; Liwen Deng; Isaac M Chiu
Journal:  Pain       Date:  2022-11-01       Impact factor: 7.926

5.  Evaluation of Recombinant Botulinum Neurotoxin Type A1 Efficacy in Peripheral Inflammatory Pain in Mice.

Authors:  Beatrice Oehler; Cindy Périer; Vincent Martin; Amy Fisher; Stéphane Lezmi; Mikhail Kalinichev; Stephen B McMahon
Journal:  Front Mol Neurosci       Date:  2022-05-26       Impact factor: 6.261

Review 6.  Developing Modern Pain Therapies.

Authors:  John Manion; Matthew A Waller; Teleri Clark; Joshua N Massingham; G Gregory Neely
Journal:  Front Neurosci       Date:  2019-12-20       Impact factor: 4.677

Review 7.  Botulinum Neurotoxins in Central Nervous System: An Overview from Animal Models to Human Therapy.

Authors:  Siro Luvisetto
Journal:  Toxins (Basel)       Date:  2021-10-22       Impact factor: 4.546

8.  Frontiers in Pain Research: A Scope of Its Focus and Content.

Authors:  Tony L Yaksh
Journal:  Front Pain Res (Lausanne)       Date:  2020-10-29

Review 9.  Toxicology and pharmacology of botulinum and tetanus neurotoxins: an update.

Authors:  Marco Pirazzini; Cesare Montecucco; Ornella Rossetto
Journal:  Arch Toxicol       Date:  2022-03-25       Impact factor: 6.168

10.  New Engineered-Botulinum Toxins Inhibit the Release of Pain-Related Mediators.

Authors:  Minhong Tang; Jianghui Meng; Jiafu Wang
Journal:  Int J Mol Sci       Date:  2019-12-30       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.